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Effect of SLC35b4 Knockdown on Total and O-Glycosylated 
Cellular Proteins in HepG2 Cell Line 
Gregory Antonios 
Abstract 
Diabetes is considered a Non-Communicable Disease (NCD). Type II diabetes is caused 
by the lack of insulin production from liver beta cells in the aftermath of insulin 
resistance. Slc35b4 encodes a protein that transports UDP-xylose and UDP-N-
acetylglucosamine from the cytosol into the golgi. UDP-N-acetylglucosamine then 
serves as both a substrate for O-linked glycosylation (O-GlcNAC) and as a negative 
feedback inhibitor of the Hexosamine Biosynthesis Pathway (HBP) pathway. Solute 
receptor SLC35b4 has been identified, using both genetic and functional studies, as a 
regulator of obesity, insulin resistance and gluconeogenesis by Yazbek et al. Over 600 
proteins are modified with the addition of an O-GlcNAC moiety and may therefore 
contribute to the phenotype. This study employs One Dimensional (1D) and Two 
Dimensional (2D) electrophoresis to investigate differentially expressed O-glycosylated 
and total proteins in a HepG2 (Human liver carcinoma cell line) SLC35b4 knockdown 
cell line. Western blot analysis, using a primary antibody against O-glycosylated proteins, 
showed one differentially expressed O-glycosylated protein in a HepG2 cell line 
knockdown of SLC35b4. Its size was estimated to be 67.5 kDa. The 2D electrophoresis 
study of SLC35b4 knockdown resulted in the differential expression of 10 proteins, 
more than 2 fold, as compared to control siRNA. Moreover, 3 of the differentially 
expressed proteins (corresponding to Spots SSP 6203, 6204 and 8102) have very close 
matches in O-glycosylated proteins of the insulin resistance pathway where O-
glycosylation might play a role in glucose synthesis. The identification of the 
differentially expressed protein is a must in order to assess SLC35b4 role in the insulin 
resistance (IR) pathway using its knockdown.  
 
Keywords: Type II diabetes, Two Dimensional electrophoresis, SLC35b4, O-
glycosylated proteins 
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GLOSSARY 
1D electrophoresis: One Dimensional electrophoresis 
1D-SDS PAGE: One Dimensional-SDS Poly Acrylamide Gel Electrophoresis 
2D electrophoresis: Two Dimensional electrophoresis 
APS: Ammonium Persulfate  
BARN: Blotting and Removing of Nitrocellulose 
BMI: Body Mass Index  
BSA: Bovine Serum Albumin  
CID: Collision-Activated Dissociation 
CR: Calorie Restriction 
CRTC2: CREB regulated transcription coactivator 2 
CSSs: Chromosome Substitution Strains  
DMEM: Dulbeco’s Modified Eagle Medium  
FBS: Fetal Bovine Serum  
GAG: glycosaminoglycan  
HBP: Hexosamine Biosynthesis Pathway  
HepG2: human liver carcinoma cell line  
IEF: Isoelectric Focusing 
IPG: Immobilized pH gradient  
IR: Insulin Resistance  
KD: Knockdown  
MALDI TOF: Matrix-Assisted Laser-Desorption/Ionization Time-Of-Flight Mass 
Spectrometry 
NCD: Non-Communicable Disease  
O-GlcNAC: O-linked glycosylation  
PBS: Phosphate Buffer Saline  
PenStrep: Penicillin-Streptomycin  
pI: Isoelectric Point  
PMF: Peptide Mass Fingerprinting  
QTLs: Quantitative Trait Loci  
SDS: Sodium Dodecyl Sulfate 
SNP: Single Nucleotide Polymorphism  
TAE: Tris-Acetate-EDTA  
TGS: Tris-Glycine-SDS
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CHAPTER ONE 
LITERATURE REVIEW 
 
1.1. Type II diabetes 
Diabetes is considered a Non-Communicable Disease (NCD). By definition, it may not 
be transmitted from one organism to another. In 2008, 57 million deaths occurred 
worldwide. NCDs, mainly cancer, cardiovascular diseases, diabetes, and chronic 
respiratory diseases were the cause of 63% (36 million) of all deaths occurring in 2008 
(Alwan et al., 2010). Diabetes alone caused 1.3 million deaths. As a disease, it may be 
categorized into 2 main branches: Type I diabetes (formerly known as insulin-dependent 
or juvenile diabetes) and Type II diabetes (formerly known as non-insulin dependent 
diabetes or adult-onset diabetes) (Shivashankar & Mani, 2011).  
Glucose discharge, in the liver, is ordinarily suppressed by insulin (Melmed et al., 2011). 
Occurring mainly within fat tissue and the liver, insulin resistance is characterized by the 
incapability of cells to react effectively to standard levels of insulin (Lippincott, 2007). 
Thus, when insulin resistance sets in, the liver unsuitably releases glucose into the blood 
(Melmed et al., 2011). Therefore, Type II diabetes is caused by the lack of insulin 
production from liver beta cells in the aftermath of insulin resistance (Masharani & 
German, 2011). The disease pathophysiology is balanced between two conditions: either 
a primary insulin resistance with only a small defect in insulin secretion or a secondary 
insulin resistance where the primary issue would be a shortage of insulin secretion 
(Masharani & German, 2011). 
Identified genetic variants of Type II Diabetes do not currently account for its 
heritability as they only justify 10% of the heritability (Billings & Florez, 2010; Wheeler 
& Barroso, 2011). Morbidity has been reduced radically by lifestyle modifications or 
medications, such as sulfonylureas or metformin, which control the resulting 
hyperglycemia but fail to achieve optimal glycemic levels. Hence, micro-vascular 
complications that are partially caused by fluctuations in glycemic levels are still an issue 
(Nathan et al., 2009).  
 
2 
 
Type II diabetes is a genetically complex disease (Freeman & Cox, 2006). Studies of 
such multifactorial traits are performed on chromosome substitution strains (CSSs) of 
mammals to obtain congenic strains that have considerable power to detect quantitative 
trait loci (QTLs) reliably and reproducibly (Yazbek et al., 2011). Mapping the molecular 
pathways and new genes involved in obesity induced type II diabetes will help in its 
prognosis. Using dual studies; genetic and functional, the solute receptor SLC35b4 was 
identified as a regulator of obesity, insulin resistance and gluconeogenesis (Yazbek et al., 
2011). 
1.2. SLC35B4 
To unravel the causal pathophysiology that in turn would offer a novel understanding of 
the molecular basis of the disease, the genetic factors stimulating diabetes and obesity 
predisposition must be identified (Altshuler et al., 2008). Towards this end, Yazbek et al. 
found that Slc35b4 hepatic expression was increased ~50% in strain 6C2d-2 relative to 
strain 6C2d-3 (p< 0.05).  Liver was also found to be insulin resistant in the euglycemic-
hyperinsulinemic clamp experiments, as evidenced by the inability to respond to insulin 
and shut down glucose production.  Together, this suggests that a liver autonomous 
defect is responsible for the hepatic insulin resistance (Yazbek et al., 2011). Variation in 
hepatic Slc35b4 expression and altered hepatic gluconeogenesis together suggest that a 
liver autonomous defect is responsible for the hepatic insulin resistance. In vitro assays 
in human liver cell line (HepG2) also showed that a 60% alteration in Slc35b4 
expression caused a 20% decrease in glucose production (Yazbek et al., 2011). 
Interestingly, a single nucleotide polymorphism (SNP) in the human SLC35B4 gene 
(rs1619682) was associated with waist circumference in the Framingham Heart Study 
(Fox et al., 2007).  The human SLC35B4 gene is located on chromosome 7q33 where 
QTLs have been reported that regulate body mass index (BMI), metabolic syndrome, 
lipid profiles, fasting glucose, pro-insulin levels, and fat stores (Arya et al., 2002; Feitosa 
et al., 2002; Tang et al., 2003; Saunders et al., 2007; Laramie et al., 2008).  Other nearby 
candidate genes includes LEPTIN and SEC8, and data obtained by Yazbek et al. indicate 
that SLC35B4 should be considered a strong candidate gene as well (Yazbek et al., 2011). 
Of note, the interval spanning 7q21.1 -7q34 appears to contain at least two genes 
influencing obesity and obesity related traits (Li et al., 2003).  Further studies are needed 
to determine whether additional QTLs are present at this locus in humans and to 
establish the causal variant underlying these QTLs. 
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Slc35b4 encodes a protein that transports UDP-xylose and UDP-N-acetylglucosamine 
from the cytosol into the golgi (Ashikov et al., 2005). Therefore, over-expression of 
Slc35b4 may alter the cellular localization of its cargo nucleotide sugars.  
1.3. O-Glycosylation 
UDP-xylose is required for glycosaminoglycan (GAG) biosynthesis on the core protein 
of proteoglycan sugar chains (Moriarity et al., 2002). Proteins that are post-translationally 
modified with a proteoglycan function in a variety of cellular and physiological activities, 
including differentiation, signaling, adhesion, cell division, and wound repair (Wang et 
al., 2007). UDP-xylose is also part of a trisaccharide found on the epidermal growth 
factor repeats of proteins, such as Notch and the coagulation Factors VII and IX (Hase 
et al., 1988; Moloney et al., 2000).  Data from mutant Chinese hamster ovary cells that 
contain cytoplasmic, but not Golgi UDP-xylose synthesis demonstrated the in vivo 
ability of cytoplasmic UDP-xylose to be incorporated into protein xylosylation in the 
Golgi (Bakker et al., 2009).  This suggests a potential role for Slc35b4, which is the only 
known cytoplasmic to Golgi transporter of UDP-xylose, in the biosynthesis of GAGs 
and protein xylosylation.   
Slc35b4 is also a transporter for UDP-N-acetylglucosamine, which is the major end 
product of the hexosamine biosynthesis pathway (HBP).  UDP-N-acetylglucosamine 
then serves as both a substrate for O-linked glycosylation (O-GlcNAC) and as a 
negative feedback inhibitor of the HBP pathway (Buse, 2006).  Alterations in the hepatic 
HBP flux lead to endoplasmic reticulum stress, lipid accumulation, and inflammation 
that could all contribute to the development of obesity and insulin resistance (IR) (Sage 
et al., 2010).  Phosphoinositide-dependent regulation of insulin signaling through O-
GlcNAC modification of Akt and IRS1 represents a molecular mechanism linking the 
HBP pathway to IR (Yang et al., 2008).  In addition, the HBP pathway stimulates hepatic 
gluconeogenesis through an insulin-independent O-GlcNAC modification of CREB 
regulated transcription coactivator 2 (CRTC2) (Dentin et al., 2008).  Although these 
individual proteins are likely important to pathogenesis, over 600 proteins are modified 
with the addition of an O-GlcNAC moiety and may therefore contribute to the 
phenotype (Love & Hanover, 2005).   
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Figure 1.1. O-Glycosylated proteins in the glucose homeostasis pathway (Teo et al., 2010).  
 
Yazbek et al. hypothesized that hepatic over-expression of Slc35b4 alters transport and 
therefore bioavailability of UDP-xylose and UDP-N-acetylglucosamine (Yazbek et al., 
2011).  Importantly, even a modest 20% increase in O-GlcNAC transferase levels leads 
to increased insulin resistance, suggesting that levels of UDP-N-acetylglucosamine levels 
are tightly regulated (McClain et al., 2002).  Therefore, the 1.5-fold increase in hepatic 
Slc35b4 mRNA levels is predicted to alter the post-translational modification of many 
proteins. 
O-GlcNAC is exclusively located in the cytoplasm and the nucleus where it modulates 
the activity of several proteins and transcription factors including Sp1, CRTC2 and 
FoxO1 (Issad & Kuo, 2008). O-GlcNAC modification sites are often identical to or 
near phosphorylation sites and can therefore regulate protein function on their own or 
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through the inhibition of phosphorylation.  The link between HSP and insulin resistance 
and diabetes has previously been shown to stimulate hepatic gluconeogenesis through 
O-GlcNAC modification of CRTC2 and FoxO1 (Lefebvre et al., 2010). In addition, 
overexpression of UDP-N-acetylglucosamine in rat muscle causes whole body insulin 
resistance (Arias & Cartee, 2005). 
Table 1.1. Insulin receptor pathway O-glycosylated proteins 
IRS 135 kDa 
PI3K 43 kDa 
PDK1 49 kDa 
Akt 55 kDa 
Mun18-c 45 kDa 
GSK3β 46 kDa 
AMPK 30 kDa 
SP1 83 kDa 
IR 156 kDa 
 
To this end, this study employs 1D and 2D electrophoresis to investigate differentially 
expressed O-glycosylated and total proteins in a HepG2 SLC35B4 knockdown cell line. 
1.4. Proteomics Expression Analysis 
Several protein analysis methods have been put to use in the field of proteomics, of 
which mass spectrometry has proved to be a proficient tool in protein and pathway 
identification (Marko-Vargas, 2005). Routine protein techniques like one dimensional 
electrophoresis and peptide mass fingerprinting, may be used to gather significant 
information about the glycosylation of glycoproteins (Wilson et al., 2009) 
1.4.1. 1D-SDS PAGE (Western Blot) 
Almost four decades ago, a technique was devised for the electrophoretic transfer of 
proteins from polyacrylamide gels to nitrocellulose paper. Immunoblotting using 
specific primary and secondary antibodies was used to detect the immobilized proteins 
(Towbin et al., 1979). As the term southern blot was already taken for the technique used 
to detect DNA using agarose gels, the technique was dubbed Western blotting and has 
become essential as a tool in the study of the presence, relative abundance, relative 
molecular mass, post-translational modification, and interaction of specific proteins 
(MacPhee, 2010).  
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1.4.2. 2D Electrophoresis 
2D electrophoresis is a form of electrophoresis where proteins are first separated based 
on their isoelectric point (pI), and then separated according to their molecular weight. 
This allows for a far better resolution than one dimensional gel electrophoresis where 
proteins are only separated according to molecular weight. (Friedman et al., 2009; 
Westermeier & Schickle, 2009). The profiling of the differentially expressed proteins can 
then be compared to gene expression array data available with pI from a previous 
experiment.  
 
Figure 1.2. 2D Workflow suggested by Bio-Rad. Upper pathway was utilized for 
the purpose of this study. 
Recently, Karthik et al. identified 4 differentially expressed proteins in a proteomic 
analysis of plasma proteins in diabetic rats by 2D electrophoresis, showing the value of 
proteomic approach in the study of the molecular basis of diabetes mellitus (Karthik et 
al., 2012). Unpublished microarray data of Yazbek et al., shows several under & over-
expressed pathways, when comparing B6 and A/J mouse models.  
1.4.3. MALDI Analysis 
Ions from biological molecules such as proteins and DNA are produced following soft 
ionization as one provided by matrix-assisted laser-desorption/ionization time-of-flight 
mass spectrometry (MALDI TOF) (Lay & Holland, 2000).  Peptide mass fingerprinting 
(PMF) and de novo sequencing are 2 ways through which MALDI TOF may be used to 
identify proteins. In PMF, a series of peptide masses are produced after proteolysis, 
enabling their detection by MALDI TOF and resulting in unique spectra for every 
protein. Databases such as SwissProt will enable the identification of most proteins after 
PMF (Marvin et al., 2003).  MALDI de novo sequencing allows sequencing of unknown 
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proteins one amino acid at a time through collision- activated dissociation (CID) 
(Seidler, 2010). 
In a previous study, Hanisch was able to successfully use the MALDI TOF/TOF to 
localize O-glycosylation sites in glycoproteins through peptide sequencing (Hanisch, 
2011).   
1.5. Objectives: 
 
- The long-term developmental objective of this research project is to apply the 
obtained knowledge enabling the development of novel therapeutic tools, which 
may lead to clinical trials and better patient treatment. 
 
- We hope to identify, through peptide mass fingerprinting, differentially expressed 
O-glycosylated proteins in the insulin resistance pathway behind type II diabetes. 
 
- The study also aims at finding and eventually identifying any differentially expressed 
proteins between a knockdown model of HepG2 cells and one of a control using 
2D electrophoresis, hypothesizing that these proteins will be involved in the insulin 
resistance pathway. 
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CHAPTER TWO 
MATERIALS AND METHODS 
 
2.1. Cell Culture of HepG2 Cells 
 Cells were maintained in Dulbeco’s Modified Eagle Medium (DMEM) (Lonza) 
containing 10% Fetal Bovine Serum (FBS) (Sigma) and 1% Penicillin-
Streptomycin (PenStrep) (Lonza) 
 Cells were detached for plating by aspirating DMEM then washing with 
Phosphate Buffer Saline (PBS) (Sigma) after which 2 mL of 1X Trypsin (Sigma) 
were added for 10 minutes then deactivated by the addition of DMEM onto 
detached cells 
 
2.2. Knockdown of SLC35b4 
 Trilencer-27 siRNA Kit (OriGene) was used to knockdown SLC35b4 in cell 
culture.  
- Kit information: SLC35b4 (Human) - 3 unique 27mer siRNA duplxes – 2 
nmol each (Cat # SR313733) 
- Modifications to manufacturer protocol:  
 Transfection reagent used was DharmaFECT 1 (Dharmacon) 
 Final siRNA concentration per well (in a 6well plate) was 100 nm  
 
2.3. One-Dimensional Electrophoresis Workflow: 
 
2.3.1. RNA Extraction 
Cells from cell culture were scraped with Trizol (Invitrogen) in order to 
maintain RNA integrity, and then RNA was extracted using Nucleospin RNA 
II (Macherey-Nagel) as per manufacturer instructions. RNA integrity was 
checked by running 8 µL of extracted RNA in a 1.5% Agarose (Bio-Rad) gel in 
1X Tris-Acetate-EDTA (TAE) buffer (Bio-Rad).  
 
2.3.2. cDNA Synthesis 
2 µL of extracted RNA was reverse transcribed into cDNA using iScript 
Reverse Transcription Supermix (Bio-Rad). 
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2.3.3. Real-Time PCR 
Fluorescence Realtime PCR assay to confirm SLC35b4 knockdown was 
performed as follows on Roche LightCycler instrument 
SLC35b4 Primers: (TIB MOLBIOL) 
Forward Primer 5' -  ggAggCTTTgTTTTATAATCACg 
Reverse Primer 5' -  AgTgATgATGTTCATgAggAggT 
 
SLC35b4 Fluorescent Probes: (TIB MOLBIOL) 
FL probe 5' -  gAACTgCATggTCATAAATATCAgAAgCC-- FL 
LC probe  5' -  LC640-AgAAgACgAAACCCggAAgTggA-- PH 
 
 A Primers/Probe mix for the internal control H6PD was obtained from the 
LightCycler h-G6PDH Housekeeping Gene Set (Roche) 
The real-time PCR conditions were set as follows:  
Vrxn = 20 µL 
SLC35b4 
Final 
Conc 
1 Reaction 
Freshly prepared Master Mix 5X LightCycler Taqman 
Master (Roche) 
1X 4 µL 
Forward Prime 300 nM 0.3 µL 
Reverse Primer 300 nM 0.3 µL 
Probe: SLC35B4 FL 300 nM 0.3 µL 
Probe: SLC35B4 LC 300 nM 0.3 µL 
Adjust volume to 15 µL with nuclease-free water   9.8 µL 
  
Total 
Volume 
15 µL 
Material to be quantified (Sample cDNA, water control)   5 µL 
 
G6PDH 
Final 
Conc 1 Reaction 
Freshly prepared Master Mix 5X LightCycler Taqman 
Master 1X 2 µL 
Primer/HybProbe Mix (detection Mix) 1X 2 µL 
MgCl2 stock solution  (25mM) 4 mM 2.4 µL 
Adjust volume to 15 µL with nuclease-free water   8.6 µL 
  
Total 
Volume 15 µL 
Material to be quantified (Sample cDNA, water control)   5 µL 
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PCR Program: 
Temperature (°C) Time Cycles Acquisitions 
50 2 min X 1 None 
95 10 min X 1 None 
95 10 sec 
X 50 
None 
57 45 sec Single 
72 5 sec None 
 
2.3.4. Protein Extraction 
Following knockdown cells were scraped in 1mL complete Laemmli buffer 
(Bio-Rad) and then lysed at 95OC for 5 min 
 
2.3.5. Protein Quantification 
The extracted proteins were quantified using the RC DC protein quantification 
assay (Bio-Rad) using a Bovine Serum Albumin (BSA) (Bio-Rad) standard curve 
in LaemmLi Buffer (Bio-Rad) 
 
2.3.6. One-Dimensional Gel Electrophoresis and Blotting     
           (Western Blot) 
2.3.6.1. Gel preparation:  
25 mL (enough for 2 mini gels, 8 cm) of 8% (Acrylamide) SDS-PAGE lower 
gel was prepared as follows:   
Component Volume 
H2O 12.1 mL 
4X Resolving Buffer* 6.25 mL 
37.5:1 Acrylamide:Bis* 6.67 mL 
10% (w/v) Ammonium Persulfate (APS)* 130 µL 
TEMED* 14 µL 
10% (w/v) Sodium dodecyl sulfate (SDS)* 100 µL 
*Marks a product from Bio-Rad 
10 mL (enough for 2 mini gels, 8 cm) of 5% (Acrylamide) SDS-PAGE upper 
gel was prepared as follows:   
Component Volume 
H2O 5.8 mL 
4X Stacking Buffer* 2.5 mL 
37.5:1 Acrylamide:Bis* 1.7 mL 
10% (w/v) Ammonium Persulfate (APS)* 40 µL 
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TEMED* 20 µL 
10% (w/v) Sodium dodecyl sulfate (SDS)* 100 µL 
*Marks a product from Bio-Rad 
2.3.6.2. Protein load and run parameters: 
 30-35 µL of protein volume in sample buffer was loaded in each well 
depending on the sample’s concentration, a total of 20 µg of protein was 
loaded per well 
 7 µL of a 10-250 Kd protein ladder (Bio-Rad) was loaded to ensure run 
and transfer efficiency 
 Tris-Glycine-SDS (TGS) 10X buffer (Bio-Rad) was diluted to 1X and 
used in electrophoresis run 
 Electrophoresis run parameters were set to 100 volts until dye front 
reached bottom of gel 
 
2.3.6.3. Transfer to nitrocellulose membrane: 
 Transfer buffer (1 L) was prepared as follows: 
Component Volume 
H2O 800 mL 
Tris (Bio-Rad) 3 g 
Glycine (Bio-Rad) 14.4 g 
Methanol* 200 mL 
*Methanol is added to the transfer preparation tray before the H2O 
(containing Tris and Glycine)  
 Nitrocellulose membrane is cut at 5.5 x 8 cm  
- Soak in Methanol for 5 sec 
- Soak in H2O for 1 min 
- Soak in transfer buffer 
 Soak gel in transfer buffer for 10 min 
 Transfer sandwich was prepared as follows: 
- Cassette white side down and black side up 
- Sponge, filter, membrane, gel, filter, sponge 
 Place sandwich in cassette holder and cover to the rim with transfer 
buffer and place magnet inside. Have black side of cassette face the black 
side of the holder. 
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 Place transfer chamber on magnetic stirrer and have magnet set to slowly 
rotate 
 Run at 110V for 1 hour 
 
2.3.6.4. Blotting with antibodies: 
 Membrane was removed and blocked with 5% non-fat milk (Regilait) in 
washing buffer 
 Washing buffer (1L) was prepared as follows and adjust pH to 7.4 using 
strong acid: 
Component Volume 
H2O 1000 mL 
Tris-Cl (Bio-Rad) 1.576 g 
NaCl 8.77 g 
Tween-20 (Bio-Rad) 0.5 mL 
 
 Membrane was removed and blocked with 5% non-fat milk (Regilait) in 
washing buffer (50mL) for 2 hours 
 Primary antibody was prepared in 1% non-fat milk in washing buffer at 
appropriate dilution 
- Membrane was incubated with 4 mL of diluted primary antibody 
overnight at 4oC in cold room on an orbital shaker 
Primary Antibody Dilution Factor 
Monoclonal Anti-β-O-Linked N-Acetylglucosamine 
antibody (Mouse) (Sigma-Aldrich) 
1:2000 
Anti-Actin antibody (Rabbit) (Sigma-Aldrich) 1:4000 
 
 Membrane was washed in washing buffer for 3X 10 min, using 25 mL of 
buffer each time 
 Secondary antibody was prepared in 1% non-fat milk in washing buffer 
at appropriate dilution 
- Membrane was incubated with 4mL of diluted secondary antibody 
for 2 hours at room temperature on an orbital shaker 
Secondary Antibody Dilution Factor 
Donkey Anti-Mouse IgG (Jackson ImmunoResearch) 1:5000 
Donkey Anti-Rabbit IgG (Jackson ImmunoResearch) 1:5000 
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 Membrane was washed in washing buffer for 3X 10 min, using 25 mL of 
buffer each time 
 Protein bands were visualized with the Immun-Star™ WesternC™ 
Chemiluminescence Kit (Bio-Rad) using the ChemiDoc™ XRS System 
(Bio-Rad) and the Quantity One 1-D Analysis software (Bio-Rad) 
 
2.3.7. Matrix-Assisted Laser Desorption Ionization - Time of 
Flight Mass Spectrometry (MALDI-TOF MS) 
 
 Differentially expressed band was excised from membrane blindly by using 
ladder and transparency print-out of captured chemiluminescence image as a 
guide 
 Protocols followed to attempt protein identification were: 
- Use of Nitrocellulose Membranes for Protein Characterization by 
Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry by 
Luque-Garcia et al.. (2006) 
- Analysis of Electroblotted Protein by Mass Spectrometry: Protein 
Identification After Western Blotting by Luque-Garcia et al.. (2008) 
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2.4. Two-Dimensional Electrophoresis Workflow: 
 
2.4.1. RNA Extraction 
Cells from cell culture were scraped with Buffer RA1 (Macherey-Nagel) in order 
to maintain RNA integrity, and then RNA was extracted using Nucleospin RNA 
II (MN) as per manufacturer instructions. RNA integrity was checked by 
running 8 µL of extracted RNA in a 1.5% Agarose (Bio-Rad) gel in 1X Tris-
Acetate-EDTA (TAE) buffer (Bio-Rad). RNA concentration/purity was 
measured using Nanodrop ND-1000 (Thermo).  
 
2.4.2. cDNA Synthesis 
500 ng of extracted RNA were reverse transcribed into cDNA using iScript 
Reverse Transcription Supermix (Bio-Rad) 
 
2.4.3. SYBR Green Real-Time PCR 
SYBR green Real-time PCR assay to confirm SLC35b4 knockdown was 
performed as follows on the Bio-Rad CFX96 touch instrument 
 Primers were designed using the SciTools Real-time PCR tool of the 
Integrated DNA technologies homepage 
SLC35b4 Primers (refseq NM_032826): (TIB MOLBIOL) 
Forward Primer AAAGCAGGTGACTTCCCAG 
Reverse Primer AATATCCCCATCCTTGCTGAC 
H6PD Primers (refseq NM_004285): (TIB MOLBIOL) 
 
*All primers were reconstituted in 650 µL of nuclease-free water in order to 
attain a concentration of 20 uM 
  
Forward Primer TGTCCTTGAGAAACCCTTTGG 
Reverse Primer GTCTCGGAAAGGCAGGATC 
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 The real-time PCR conditions were set as follows:  
Vrxn = 20 µL 
SLC35b4 
Final 
Conc 
1 Reaction 
iQ SYBR green supermix (2X) 1X 10 µL 
Forward Primer 300 nM 0.3 µL 
Reverse Primer 300 nM 0.3 µL 
Adjust volume to 17 µL with nuclease-free water   6.4 µL 
  
Total 
Volume 
17 µL 
Material to be quantified (Sample cDNA, water control)   3 µL 
 
H6PD 
Final 
Conc 
1 Reaction 
iQ SYBR green supermix (2X) 1X 10 µL 
Forward Primer 300 nM 0.3 µL 
Reverse Primer 300 nM 0.3 µL 
Adjust volume to 17 µL with nuclease-free water   6.4 µL 
  
Total 
Volume 
17 µL 
Material to be quantified (Sample cDNA, water control)   3 µL 
PCR Program: 
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 A serial dilution standard curve, both for SLC35b4 and H6PD, was run 
parallel to samples and the Real-time PCR report was generated by the CFX 
manager software.  
 
2.4.4. Protein Extraction 
Following knockdown cells were scraped in 1mL 2D sample buffer (Bio-Rad) 
and then proteins were extracted using the ReadyPrep Total Protein Extraction 
Kit (Bio-Rad) according to manufacturer’s instructions 
 
2.4.5. Protein Quantification 
The extracted proteins were quantified using the RC DC protein quantification 
assay (Bio-Rad) using a Bovine Serum Albumin (BSA) (Bio-Rad) standard curve 
in 2D sample buffer (Bio-Rad) following the manufacturer’s instruction, 
including: 
 Two washes were performed using the RC reagents 
 Protein pellet was dried under vacuum centrifugation for 40min before 
proceeding to adding DC reagents 
 
2.4.6. Protein Cleanup 
The extracted proteins were cleaned using the ReadyPrep 2D cleanup kit (Bio-
Rad) following the manufacturer’s instructions  
 
2.4.7. Two-Dimensional Gel Electrophoresis  
2.4.7.1.  Sample rehydration 
 400 μg of cleaned protein in 300 µL of 2D sample buffer were placed in 
a 17 cm tray and 17 cm pH 3-10 ReadyStrip IPG strips were placed gel-
side down over sample buffer and covered with 3mL mineral oil (Bio-
Rad) and left to rehydrate overnight (12 hours) 
2.4.7.2.  Isoelectric focusing (IEF)  
 IEF was performed on PROTEAN® i12™ IEF System (Bio-Rad) 
 Strips were drained from oil then transferred to IEF focusing tray gel-
side up 
 Wetted electrode wicks were placed at the ends of strip 
 Electrodes were then installed in their place at tray ends 
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 Strips were overlaid with 7mL of mineral oil 
 Focusing conditions were as follows: 
Start 
voltage 
End 
voltage 
Volt-hours Ramp Temperature 
0 V 10,000 V 40,000 V-hr Rapid 20oC 
 
2.4.7.3. SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) 
 40 mL (enough for 1 XL gel) of 10% (Acrylamide) SDS-PAGE upper 
gel was prepared as follows:   
Component Volume 
H2O 16.8 mL 
4X Resolving Buffer* 10 mL 
37.5:1 Acrylamide:Bis (30%)* 13.36 mL 
10% (w/v) APS* 210 µL 
TEMED* 23 µL 
10% (w/v) SDS* 160 µL 
*Marks a product from Bio-Rad 
 Prior to addition of TEMED and APS to gel solution. The solution was 
degased for 3min then APS and TEMED were added and solution 
swirled gently 
 Gel solution was poured between glass plates then IPG comb 
(containing well for ladder) was placed (gels need around 40 min to 
solidify) 
 Prior to placing IPG strips on gel plates, IPG comb was removed and 
IPG well was washed with 1X TGS buffer 
 Preparation of Equilibration buffer: 
- 6 M Urea, 0.375 M Tris-HCl (pH 8.8), 2% w/v SDS, 20%v/v 
glycerol 
 Drain strips from oil and transfer them to a new tray  
 Add 5 mL Equilibration buffer I: Equilibration buffer + 2% w/v DTT 
(Bio-Rad) and place tray on orbital shaker for 10min 
 Melt overlay Agarose (Bio-Rad) in microwave for 30 sec then leave to 
cool in room temperature 
 Discard Equilibration buffer 1 and add Equilibration buffer II: 
Equilibration buffer + 2.5% w/v Iodoacetamide (Bio-Rad) and place 
tray on orbital shaker for 10 min 
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 Discard Equilibration buffer II and fill 100 mL graduated cylinder with 
1X TGS buffer 
 Dip IPG strips in 1X TGS buffer 5-6 times in order to get rid of excess 
equilibration buffer 
 Lay the strip gel-side up on back plate of the gel 
 Cut off the plastic edges off the IPG strip 
 Place overlay agarose into IPG well and gently ease IPG strip through 
agarose downward until it comes to contact with gel below 
 Stand gels vertically and allow agarose to solidify for 5 min prior to 
mounting them in the electrophoresis cell  
 Fill upper and lower reservoir chambers with 1X TGS buffers 
 Run conditions were set as 16 mA/gel for 30 min, 24 mA/gel for 5 
hours 
2.4.7.4.  Staining 
 Fill staining tray with distilled water 
 After the SDS-PAGE run has ended, the gel cassette was opened and 
placed in the tray on a rocker 
 The gel was washed 3 times for 5 min each, adding fresh distilled water 
for each wash 
 Add BioSafe Coomassie stain (Bio-Rad) and stain the gel for 60 min 
 Discard the stain and wash twice for 15 min each with distilled water 
2.4.7.5.  Imaging 
 The gel was scanned using Bio-Rad’s GS-800 calibrated imaging 
densitometer and image was aquired using the Quantity One software 
(Bio-Rad) 
2.4.7.6.  Analysis 
 Analysis of differentially expressed proteins was performed using 
PDQuest software (Bio-Rad) 
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CHAPTER THREE 
RESULTS 
 
3.1.  One-Dimensional Electrophoresis Workflow: 
 
3.1.1. RNA Extraction 
 
RNA integrity was confirmed since bands for mRNA, rRNA and tRNA were 
visible and no smear was observed (Figure 3.1). 
 
Fig. 3.1. 1.5% Agarose gel showing extracted RNA and transcribed cDNA. Bands for 
tRNA, mRNA and rRNA are visible without streaking thus validating RNA use for 
Real-Time PCR. 
 
3.1.2. Real-Time PCR 
 
Fluorescence Real-time PCR assay was performed on the transcribed cDNA to 
confirm SLC35b4 knockdown (KD) in the HepG2 cells (Figure 3.2), using 
G6PDH (H6PD) gene as a reference gene (Figure 3.3).  
 
Two samples of both KD (KD1 & KD2) and control (CTL2 & CTL3) were run 
in duplicates and all sample curves overlap. Positive control (human) from RNA 
extracted and reverse transcribed and gave a positive result. Negative control 
showed (Ct = 37.05) and may be attributed to primer dimers. 
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Fig. 3.2. SLC35b4 KD real-time PCR amplification curves using Roch LightCycler 2.0. 
Two amplification curves are noticeable: to the left are the amplification curves for the 
2 control samples run in duplicates and the right are the amplifications curves for the 2 
knockdown samples run in duplicates.  
 
 
Fig. 3.3. G6PDH real-time PCR amplification curves using Roch LightCycler 2.0. One 
main amplification curves is  noticeable: starting around 22 cycles are all amplification 
curves for both control and knockdown samples for the H6PD reference gene. One 
control sample and a negative sample are to the right.  
 
Knockdown of SLC35b4, using H6PD as a reference gene, was calculated using 
the ΔCq method as shown in Table 3.1. Efficiencies of both reactions were 
assumed to be 100%. Final expression of SLC5b4 is calculated by dividing final 
averages, yielding an expression of 0.42 as compared to an expression of 1 for 
the H6PD reference. This indicates a 58% knockdown of the SLC35b4 mRNA 
in the samples. 
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Table 3.1.  ΔCq calculations of SLC35b4 expression with respect to H6PD. Final 
relative expression is calculated by dividing KD averages by Ctrl averages to obtain a 
decrease of 58% in expression of SLC35b4 between KD and control samples  
  
G6PDH 
Ct  
G6PDH 
Average  
SLC35b4 
KD Ct 
SLC35b4 KD 
Average  
Cycle 
Difference 
Normalized by 
reference gene  
Average  
Ctrl 
2 
21.2 
21.16 
28.96 
28.975 -7.775 0.004565536 
0.005006877 
21.12 28.99 
Ctrl 
3 
21.3 
21.37 
28.81 
28.82 -7.52 0.005448217 
21.44 28.83 
KD 
1 
22.17 
22.19 
30.31 
30.63 -8.46 0.00283979 
0.002147277 
22.21 30.95 
KD 
2 
21.54 
21.595 
30.97 
30.965 -9.425 0.001454763 
21.65 30.96 
 
Relative expression of SLC35b4 in knockdown samples as calculated by the ΔCq 
method indicated a 58% decrease in expression with respect to H6PD (Figure 
3.4). 
 
 
Fig. 3.4.  Bar graph showing relative expression of SLC35b4 with respect to H6PD. 
 
3.1.3. Protein Quantification 
 
After confirmation of knockdown of SLC35b4 gene, proteins were extracted 
from the KD and control (Ctrl) HepG2 cells, and their concentration was 
determined using Bovine Serum Albumin for the standard curve (Table 3.2, 
Figure 3.5 & Table 3.3). 
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Table 3.2. Absorbance values obtained for BSA standard curve. 
BSA Standard Curve 
Concentration 
(mg/mL) 
Absorbance 1 
(λ = 750 nm) 
Absorbance 2 
(λ = 750 nm) 
Absorbance 
Average 
1.5 0.8633 0.89 0.877 
0.75 0.771 0.75 0.761 
0.375 0.7 0.716 0.708 
0.18 0.691 0.656 0.674 
 
 
Fig. 3.5. Graph for BSA standard curve along with the best-fit linear trendline and R 
value. 
 
Concentration of samples were calculated by replacing their corresponding 
absorbance values in the formula, y = 6.5563x - 4.2465, in place of the 
unknown “x”. Results are shown in Table 3.3. 
 
Table. 3.3. Absorbance values obtained for KD and Ctrl samples and their 
corresponding concentration from the standard curve trendline formula. 
Samples 
Sample 
Absorbance 1 
(λ = 750 nm) 
Absorbance 2 
(λ = 750 nm) 
Absorbance 
Average 
Concentration 
(mg/mL) 
KD 1 0.713 0.853 0.783 0.887 
KD 2 0.721 0.874 0.798 0.982 
Ctrl 2 0.845 0.84 0.843 1.277 
Ctrl 3 0.829 0.895 0.862 1.405 
 
 
y = 6.5563x - 4.2465 
R² = 0.9994 
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3.1.4. One-Dimensional Gel Electrophoresis and Blotting  
    (Western Blot) 
 
The extracted proteins were run on 1D gel and blotted using a primary 
antibody against O-glycosylated proteins (Figure 3.6 & Figure 3.7). Equal 
loading was ensured by loading 20 μg of protein per well and placing 2 
overlapping membranes during transfer the second of which was blotted using 
Actin primary antibody. Captured membrane image as shown in Figure 3.6 (40 
seconds exposure time) reveals 7 distinct bands corresponding to O-
glycosylated proteins. 
 
Fig. 3.6. Western blot of O-glycosylated proteins in HepG2 cell line. Seven bands 
corresponding for O-glycosylated proteins are noticed.  
 
One differentially expressed protein is apparent as shown in Figure 3.7 between 
KD sample and control siRNA. Band is between 50-70kDa as indicated by 
ladder. Actin loading control, from second membrane blotted by Actin primary 
antibody, shows that loading was equal. 
 
Fig. 3.7. Western blot showing difference in expression between KD and control of 
SLC35b4 using Actin as a loading control. A 65% reduction in protein X in noticeable.  
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Plotting the log of the protein size (kDa) of the ladder versus the distance they 
travelled (cm) (Figure 3.8), a linear trend is apparent and may be used to 
calculate the size of protein “X”. 
 
  
Figure 3.8. 1D standard curve of log of protein molecular weight (MW) vs. Ratio of 
Fronts (Rf) 
 
3.1.5. Matrix-Assisted Laser Desorption Ionization - Time of 
Flight (MALDI-TOF) 
 
- Trials to identify differentially expressed bands were conducted as per 
authors’ instructions as mentioned in section 2.4.7 in Materials and 
Methods.  
- Attempts were made to both strip membrane from proteins and extract 
proteins from it without stripping 
- All resulting spot spectra showed 40-45% noise intensity and protein 
identification was not possible 
 
  
y = -1.3401x + 2.6224 
R² = 0.979 
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3.2. Two-Dimensional Electrophoresis Workflow: 
 
3.2.1. RNA Extraction 
 
RNA integrity was confirmed since bands for mRNA, rRNA and tRNA were 
visible and no smear was observed (Figure 3.9). 
 
Fig. 3.9. 1.5% Agarose gel showing extracted RNA and transcribed cDNA. Bands for 
tRNA, mRNA and rRNA are visible without streaking thus validating RNA use for 
Real-Time PCR.  
 
RNA concentration was checked using the Nanodrop in order to ensure equal 
amount of RNA is reverse transcribed (Table 3.4). Also 260/280 ratios were 
obtained in order to ensure RNA purity and absence of protein contamination. 
All values were close to 2 ensuring that samples may be used in reverse 
transcription.  
 
Table 3.4. Absorbance values of extracted RNA as measured using Nanodrop.  
Sample 
Concentration 
(ng/µL) 
Absorbance 
ratio 260/280 
KD RNA 1 263.1 2.13 
KD RNA 2 192.5 2.15 
Ctrl RNA 1 551.1 2.09 
Ctrl RNA 2 270 2.07 
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3.2.2. SYBR Green Real-Time PCR 
 
Standard curve results of SLC35b4 serial dilution show an efficiency of 99.8% 
and a perfect linear fit. Samples were diluted 1/10 each time.  Standard curve 
samples were run in triplicates and outliers were excluded from graph (Figure 
3.10).  
 
 
Fig. 3.10. Standard curve results of SLC35b4 dilution series. Five dilutions of DNA, 
each 1/10 from the previous, were performed and the standard curve generated. An 
efficiency of 99.8% was obtained.  
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Standard curve results of H6PD serial dilution (Figure 3.11) show an efficiency 
of 95.5% and a perfect linear fit. Samples were diluted 1/10 each time.  Standard 
curve samples were run in triplicates and last 2 serial dilutions were excluded 
from graph because their quantity was too thinned out and did not exhibit any 
real-time amplification.  
 
 
Fig. 3.11. Standard curve results of H6PD dilution series. Five dilutions of DNA, each 
1/10 from the previous, were performed and the standard curve generated. An 
efficiency of 95.5% was obtained. 
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Amplification curve results of knockdown and control samples were run in 
duplicates. All duplicates gave very similar Cq values and were statistically valid. 
Negative control samples for both SLC35b4 KD and control generated a curve 
at a Cq > 35 which may be attributed to primer dimers (Figure 3.12).  
 
 
Fig. 3.12. Amplification curves of knockdown and control samples both for SLC35b4 
and H6PD. Negative control samples to the right display what seem to be primer 
dimers.  
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Melt curve and melt peak results of knockdown and control samples were 
generated. Two melt peaks were observed (Figure 3.13), one corresponding for 
SLC35b4 at 81.5o C and another for H6PD at 85.5o C, indicating that no other 
product’s amplification except these two was recorded. All SLC35b4 melt peaks 
were perfectly overlaid, as well as all melt peaks corresponding to samples from 
H6PD amplifications. Primer dimers, as previously mentioned, were also 
observed at 75o C to the left. 
 
 
Fig. 3.13. Melt curve and melt peak analysis of both SLC35b4 and H6PD. Two peaks 
corresponding for H6PD and SLC35b4 are noticeable. Negative control samples 
display insignificant amplification. 
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Normalized gene expression (Figure 3.14) was calculated using the ΔΔCq 
method by the CFX Manager software. Results indicate no significant change of 
gene expression for KD 1 with respect to Control 1, and no significant change 
of gene expression of KD 2 with respect to Control 2. High error bars were 
observed in Control 1 normalized expression.  
 
 
Fig. 3.14. SLC35b4 gene expression, using H6PD as a reference gene, as calculated 
using the ΔΔCq method by the CFX Manager software. Calculations do not show 
significant relative expression difference between knockdown and control samples for 
SLC35b4. 
 
3.2.3. Protein Quantification 
 
Proteins were extracted from the KD and control HepG2 cells, and their 
concentration was determined using Bovine Serum Albumin for the standard 
curve (Table 3.5, Fig. 3.15 & Table 3.6). 
 
Table 3.5. Absorbance values obtained for BSA standard curve. 
BSA Standard Curve 
Concentration 
(mg/mL) 
Absorbance 1 (λ 
= 750 nm) 
Absorbance 2 (λ 
= 750 nm) 
Absorbance 
Average 
3 0.494 0.465 0.480 
1.5 0.316 0.326 0.321 
0.75 0.235 0.231 0.233 
0.375 0.185 0.21 0.198 
0.18 0.183 0.177 0.180 
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Fig. 3.15. Graph showing absorbance values obtained for BSA standard curve along 
with the best fit linear trendline and R value. 
 
Concentration of samples were calculated by replacing their corresponding 
absorbance values in the formula, y = 9.3021x - 1.4659, in place of the unknown 
“x”. Results are shown in Table 3.6. 
 
Table 3.6. Absorbance values obtained for KD and Ctrl samples and their 
corresponding concentration from the standard curve trendline formula. 
Samples 
Sample 
Absorbance 1 
(λ = 750 nm) 
Absorbance 2 
(λ = 750 nm) 
Absorbance 
Average 
Concentration 
(mg/mL) 
KD 1 0.355 0.365 0.360 1.883 
KD 3 0.372 0.378 0.375 2.022 
Ctrl 1 0.473 0.447 0.460 2.813 
Ctrl 3 0.551 0.548 0.550 3.646 
 
 
 
 
 
 
y = 9.3021x - 1.4659 
R² = 0.9993 
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3.2.4. One-Dimensional Gel Electrophoresis 
 
Protein extraction using a standard 1D Laemmli buffer and using the Bio-Rad 
total protein extraction kit was compared to evaluate protein extraction method. 
Both extraction methods used yielded clean 1D gels (Figure 3.16). The extraction 
kit yielded a higher number of protein bands in the high molecular weight as 
compared to the standard extraction using Laemmli buffer, and resulted in 
similar protein bands in the low molecular weight proteins.  
 
 
Fig. 3.16. 8% SDS-PAGE gel using HepG2 proteins extracted using (A) Laemmli 
buffer and heated for 3min at 95o C, (B) Bio-Rad’s Total protein extraction kit. 
Extraction kit proves more efficient than standard Laemmli buffer extraction as it 
shows more protein bands in the high molecular weight.   
 
3.2.5. Two-Dimensional Gel Electrophoresis  
 
3.2.5.1.  Imaging 
Total proteins extracted from HepG2 cell lines were subjected to IEF on 
17cm IPG strips pH 3-10 and ran on 8% SDS-PAGE gels without (Gel A, 
Figure 3.17) and with cleaning (Gel B, Figure 3.17) the protein sample 
prior to IEF strip rehydration. Better protein resolution and spot 
separation, as well as a decrease in vertical streaking, was attained with 
cleanup and thus it was decided that KD and control samples will be 
cleaned prior to IEF. 
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Fig. 3.17. Enhancement of protein spot separation and resolution using cleanup 
kit after total protein extraction. Gel (bottom) run after total protein extract was 
cleaned using Bio-Rad Clean-up Kit shows better spot separation and less vertical 
streaking.  
  
34 
 
Total proteins extracted (400 μg) from 3 KD and 3 Control samples were 
cleaned. IEF was performed on 17cm IPG strips ph 3-10 and ran on 10% 
2D gels. One KD and control sample were excluded from the analysis 
because gels were not adequate. Two KD samples and 2 control samples 
were used to create a “Master Gel” (Figure 3.18), which overlays all 
existing gels for comparison purposes using the PDQuest software. Two 
protein clusters appear to be differentially expressed to the naked eye. 
 
Fig. 3.18. 2D Master gel, Control gels and KD gels. PDQuest software combines all 
gels into one “Master Gel” which is used as a reference. Visually, 2 proteins (circled in 
red) are noticed to be differentially expressed (Under-expressed) between control (up) 
and knockdown (below) gels where they are absent.  
 
  
35 
 
3.2.5.2.  Analysis 
The selection criteria for differential expression analysis was selected to be all 
proteins differentially expressed (over-expressed or under-expressed) more 
than 2 times within a 90% confidence interval using the students’ t-test. False 
positives, due to vertical or horizontal streaks, were then omitted from 
analysis. Ten differentially expressed proteins were observed (Figure 3.19), 7 
of which were under-expressed with respect to control gels, and 3 of which 
were over-expressed. Figure 3.19 shows the proteins respective distribution 
on the gels. 
 
Fig. 3.19. Localization of the differentially expressed proteins on the 2D gels. After 
filtering though selection criteria of 2 fold difference and a 90% significance levels, 10 
differentially expressed proteins may be noticed between control (up) and knockdown 
samples (down). This figure shows the location of those proteins on all gels including 
the master gel.  
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Table 3.7 shows the differentially expressed spots where 3 over-expressed 
proteins are highlighted in “Green” color and 7 under-expressed proteins are 
highlighted in “Purple” color. Values indicated in table are intensity values of 
spots as given by software following gel scan and analysis. Blank values are 
where software indicates a total absence of intensity. Some spots indicated by 
software were slightly shifted to the left or right causing a false reading of 
intensity. 
Table 3.7. List of differentially expressed spots between knockdown and control of 
SLC35b4.  
 
 
 
 
 
 
 
 
Spot SSP 2406 was localized correctly in all 4 gels and is under-expressed by 3.6 
times as compared to the control gel (Figure 3.20). Manually averaging 
intensities of control gels and dividing by averaged intensities of KD gels 
determined relative expression. 
Fig. 3.20. Spot SSP 2406. Protein is under-expressed by 3.6 when comparing and averaging 
absorbance values for control gels as compared to knockdown gels of SLC35b4.   
SSP Control 1 Control 3 KD1 KD3 
502 60 103     
1402 29.3 39.6     
2408 41.8 66.3     
5401 9.4 11.7     
6203 1   10.6 7.7 
2406 52.8 66.3 12.2 20.8 
2409 41 30.5 0.2   
6204 11.6 18.7 34.1 35 
6501 303.6 310.9 10.7 28.6 
8102 0.6 11.3 41.5 35.6 
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Spot SSP 2409 was localized correctly in all 4 gels and is completely under-
expressed as intensity values from KD gels are negligible leading to the 
conclusion that protein expression was totally inhibited (Figure 3.21).  
 
Fig. 3.21. Spot SSP 2409. Protein is completely under-expressed when comparing and averaging 
absorbance values for control gels as compared to knockdown gels of SLC35b4. 
 
Spot SSP 6204 was localized correctly in all 4 gels (although it should be noted 
that its localization in Control Gel 1 v2 is slightly shifted to the left, but that this 
did not affect analysis) and is over-expressed by 2.28 times as compared to the 
control gel (Figure 3.22).  
 
Fig. 3.22. Spot SSP 6204. Protein is over-expressed by 2.28 when comparing and averaging 
absorbance values for control gels as compared to knockdown gels of SLC35b4.  
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Spot SSP 6501 was localized correctly in all 4 gels (although it should be noted 
that it seemed more of a protein cluster (Figure 3.23). It was hard to determine 
whether it was several protein isoforms that were adjacent to each other or a 
single protein found in a high quantity that caused a horizontal smear) and is 
under-expressed by 15.6 times as compared to the control gel.  
 
Fig. 3.23. Spot SSP 6501. Protein is under-expressed by 15 .6 when comparing and averaging 
absorbance values for control gels as compared to knockdown gels of SLC35b4. 
 
SSP 8102 was localized correctly in all 4 gels (although it should be noted that its 
localization in Control Gel 1 v2 is slightly shifted to the left, but that this did not 
affect analysis) and is over-expressed by 6.42 times as compared to the control 
gel (Figure 3.24).  
Fig. 3.24. Spot SSP 8102. Protein is over-expressed by 6.42 when comparing and averaging 
absorbance values for control gels as compared to knockdown gels of SLC35b4. 
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Spot SSP 0502 was localized correctly in all 4 gels (although it should be noted 
that it is part of a protein cluster that was under-expressed) and is completely 
under-expressed as intensity values from KD gels are negligible leading to the 
conclusion that protein expression was totally inhibited (Figure 3.25).  
 
Fig. 3.25. Spot SSP 0502. Protein is completely under-expressed when comparing and averaging 
absorbance values for control gels as compared to knockdown gels of SLC35b4. 
 
Spot SSP 1042 localized correctly in all 4 gels (although it should be noted that it 
is part of a protein cluster that was under-expressed, 3 in total: SSP 1042, 5401 
and 2409) and is completely under-expressed as intensity values from KD gels 
are negligible leading to the conclusion that protein expression was totally 
inhibited (Figure 3.26). 
 
Fig. 3.26. Spot SSP 1042. Protein is completely under-expressed when comparing and averaging 
absorbance values for control gels as compared to knockdown gels of SLC35b4. 
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Spot SSP 2406 was localized correctly in all 4 gels (although it should be noted 
that it is part of a protein cluster that was under-expressed, 3 in total: SSP 1042, 
5401 and 2409) and is completely under-expressed as intensity values from KD 
gels are negligible leading to the conclusion that protein expression was totally 
inhibited (Figure 3.27).  
 
Fig. 3.27. Spot SSP 2406. Protein is completely under-expressed when comparing and averaging 
absorbance values for control gels as compared to knockdown gels of SLC35b4. 
 
Spot SSP 5401 was localized correctly in all 4 gels (although it should be noted 
that it is part of a protein cluster that was under-expressed, 3 in total: SSP 1042, 
5401 and 2409) and is completely under-expressed as intensity values from KD 
gels are negligible leading to the conclusion that protein expression was totally 
inhibited (Figure 3.28). 
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Fig. 3.28. Spot SSP 5401. Protein is completely under-expressed when comparing and averaging 
absorbance values for control gels as compared to knockdown gels of SLC35b4. 
 
Spot SSP 6203 was localized correctly in all 4 gels and is over-expressed by 9.15 
times as compared to the control gel (Figure 3.29). Manually averaging 
intensities of control gels and dividing by averaged intensities of KD gels 
determined relative expression. 
 
Fig. 3.29. Spot SSP 6203. Protein is over-expressed by 9.15 when comparing and averaging 
absorbance values for control gels as compared to knockdown gels of SLC35b4. 
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Using the 2D gels of Ctrl 1 and Ctrl 3 and plotting the log of the protein size 
(kDa) of the ladder versus the distance they travelled (cm) (Figure 3.30), a linear 
trend is apparent and may be used to calculate the size of the differentially 
expressed proteins.  
 
Figure 3.30. 2D standard curve of log of protein molecular weight (MW) vs. Ratio of 
Fronts (Rf) 
 
Results of an estimation of both MW and pI from Ctrl 1 and Ctrl 3 2D gels are 
displayed in Table 3.8. 
Table 3.8. Respective estimation of size and pI of differentially expressed proteins 
Spot pI MW 
SSP 502 4.6 ± 0.1 70.0 ± 0.2 
SSP 6501 6.3 ± 0.1 70 ± 1 
SSP 5401 6.05 ± 0.1 61.8 ± 0.6 
SSP 6203 6.5 ± 0.0 50.34 ± 0.01 
SSP 6204 6.5 ± 0.0 46.37 ± 0.03 
SSP 8102 7.2 ± 0.0 42.01 ± 0.07 
CLUSTER* 5.5 ± 0.1 64.4 ± 0.2 
*The protein cluster mentioned in the table comprised the following spots: SSP 1402, 
SSP 2408, SSP 2406 and SSP 2409.  
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CHAPTER FOUR 
DISCUSSION 
 
4.1. One-Dimensional Electrophoresis Workflow: 
 
4.1.1. Real-Time PCR 
 
Using G6PDH (H6PD) as a reference gene, the relative expression of SLC35b4 
in knockdown samples as calculated by the ΔCq method indicated a 58% 
decrease in expression (Figure 3.4). This is comparable to results obtained by 
Yazbek et al. (2011) who demonstrated a relative expression of >50% following 
KD of SLC35b4. In comparison though, Yazbek et al.. used the 18S rRNA as a 
reference gene. They also employed the ΔΔCq method.  
 
4.1.2. One-Dimensional Gel Electrophoresis and Blotting  
(Western Blot) 
 
Arias & Cartee (2005) were able to identify 8 bands, from liver protein, using 
the same primary antibody for O-glycosylated proteins that we used. Their 
study was aimed at identifying differentially expressed O-glycosylated proteins 
between calorie restricted (CR) and control group of mice. No effect of CR 
restriction was found on O-glycosylated proteins in liver. The study was 
intended to follow whether a previously described CR-induced decrease in 
hexosamines by Gazdag et al.. (2000) was accompanied by a change in protein 
O-glycosylation status in rat muscle and liver tissue (Arias & Cartee, 2005; 
Gazdag et al., 2000). 
 
Our study was able to identify 7 bands of O-glycosylated proteins from the 
HepG2 cell line (Liver hepatocellular carcinoma cells). Bands observed ranged 
in size from 35-270 kDa. 
 
Following KD of SLC35b4, a subsequent western blot that compared between 
a control siRNA and the KD triplex siRNA revealed one differentially 
expressed protein between the 50 and 75 ladder markers. The expression of 
protein “X” was decreased by approximately 65% as compared to control 
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siRNA. When matching the approximate protein size with possible glycosylated 
proteins in the insulin resistance pathway, Protein Kinase B (Akt) is the most 
likely candidate.  
 
After replacing for the unknown (x) in the trendline of standard curve (Figure 
3.8), the size of protein X was determined to be 67.5 kDa. This does not match 
any of the glycosylated proteins in the insulin resistance pathway but may 
indicate a protein downstream or upstream of the pathways perhaps.  
  
4.1.3. Matrix-Assisted Laser Desorption Ionization - Time of Flight 
(MALDI-TOF) 
 
As mentioned in the results section 3.2.5, we were unable to identify the 
differentially expressed protein “X” by MALDI using protocols, referred to 
as Blotting and Removal of Nitrocellulose (BARN), by Luque-Garcia et al.. 
(2006, 2008). We attempted identification of protein “X” Peptide Mass 
Fingerprinting (PMF), however, the identification was not possible for the 
following reasons:  
- Both protocols used soluble (myoglobin and BSA) and membrane 
(uroplakins II and III) proteins that only contained 3-4 proteins/well on 
the 1D SDS-PAGE, this in turn resulted in the transfer of a 3-4 
protein/well to the nitrocellulose membrane 
 Since we were running total protein lysate, cutting and identification 
of one band would actually entail the identification of several 
proteins at once. 
 Also, stripping of the membrane from primary and secondary 
antibodies failed repeatedly (which is why we resorted to the 2 
overlapping membranes for Actin probing). The antibodies are of 
high molecular weight and would cause interference (a higher 
signal) than any other protein to be identified. 
- Luque-Garcia’s et al.. (2006, 2008) protocol suggested the use of a non-
protein based blocking buffer following the transfer to nitrocellulose 
membrane. We were not able to procure such a buffer and blocking was 
done using 1% non-fat milk that in itself contains a variety of proteins 
which could mask the signal of proteins to be identified.  
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4.2. Two-Dimensional Electrophoresis Workflow: 
 
4.2.1. SYBR Green Real-Time PCR 
 
Although real-time results indicated no significant change of gene expression 
for KD 1 with respect to Control 1, and no significant change of gene 
expression of KD 2 with respect to Control 2, the differentially expressed 
proteins from the 2 KD gels as compared to the 2 Control gels verify the 
knockdown using the tri-silencer siRNA. 
 
A study by Holmes et al. (2010), describes a phenomenon that gives rise to false 
negatives when validating a KD using real-time PCR.  Their data suggests that 
for certain mRNAs, degradation of the 3' mRNA fragment leaves an mRNA 
fragment that can act as a template for cDNA synthesis, giving rise to false 
negative results and the rejection of a valid siRNA duplex. They show that 
careful design of RT-qPCR primers in such a way to avoid the above-
mentioned phenomenon is possible and compare to validation by western blot 
(Holmes et al.., 2010).  
 
4.2.2. Two-Dimensional Gel Electrophoresis  
 
It is estimated that 50% of all proteins are glycosylated, and among the currently 
known Post Translational Modifications (PTMs), glycosylation has been widely 
recognized as one of the most influential parameters in the alteration of protein 
2-dimensional electrophoresis (2-DE) patterns.  This modification alters the 
apparent molecular weight of a protein, and when charged monosaccharides, 
such as sialic acids or sulphated monosaccharides, are added to N or O-glycan 
chains, the pI of the protein is also changed. (Zhang & Williamson, 2005; 
Barrabés et al.., 2010).  
 
When the 1D workflow was halted by the fact that we were not able to identify 
the differentially expressed protein, 2D electrophoresis was the next step in 
attempting to identify the effect of SLC35b4 knockdown.   
 
The estimated size of the differentially expressed proteins was determined by 
plotting the log of molecular weight of ladder proteins versus the Rf value 
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(Figure 4.2). The graph exhibited a linear trend. Since only two data points were 
available per protein, separate standard curves were generated from gels of 
Control 1 and Control 3, a linear fit applied and the molecular weight of the 
proteins computed. The values were then averaged and standard deviation 
calculated. The standard curves are shown in Figure 4.3 and the results are 
summarized in Table 4.1.  
Also, protein Isoelectric points were determined by dividing the gel in a linear 
manner from 3-10 (pH) since the strip’s gel assumes a linear graduation from pH 
3 to pH 10. A similar technique was followed by Wilson et al. (2002), where they 
estimated pI based on linear pI gradient measurement from the 1st dimension 
strip and then compared values to actual protein MW and pI after identification 
through mass spectrometry (Wilson et al.., 2002).  
Identification of differentially expressed proteins is a must before suggestion the 
possible role of the KD of the SLC35b4 receptor in the insulin resistance 
pathway (on both O-glycosylated and non O-glycosylated proteins).  
 
Interestingly however, all of the over-expressed proteins (3) have very close 
matches in molecular weight (Table 4.1) to O-glycosylated proteins of the IR 
pathway mentioned in Table 1.1. 
 
Table 4.1. Possible matches of proteins in the IR pathway O-glycosylated proteins 
showing that 3 spots’ molecular weight match some protein in the pathway. 
O-glycosylated 
proteins of Insulin 
receptor pathway 
MW 
Proposed match from differentially 
expressed proteins 
IRS 135 kDa -- 
PI3K 43 kDa SSP 8102 (MW= 42.01 ± 0.07 kDa) 
PDK1 49 kDa SSP 6203 (MW= 50.34 ± 0.01 kDa) 
Akt 55 kDa -- 
Mun18-c 45 kDa -- 
GSK3β 46 kDa SSP 6204 (MW= 46.37 ± 0.03 kDa) 
AMPK 30 kDa -- 
SP1 83 kDa -- 
IR 156 kDa -- 
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In conclusion, although this study was not able to identify the 10 differentially 
expressed proteins between the knockdown and control gels of SLC35b4, but it 
was able to optimize the 2-DE method needed to do so. Thus, future work needs 
to validate the knockdown of SLC35b4 using the SYBR green Real-Time PCR, 
and this may be done by designing new primers that would not result in the false 
negative result that was obtained. Also, since all differentially expressed proteins 
fell in the 4-7 isoelectric point range, it would also be beneficial to repeat the 2D 
electrophoresis on 4-7 pH strips and consequently obtained a better resolution. 
Finally, to assess the role of SLC35b4 in insulin resistance using its knockdown, it 
is imperative to identify the differentially expressed proteins using mass 
spectrometry and then proceed with pathway analysis.   
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CHAPTER FIVE 
CONCLUSIONS 
 
 Western blot analysis showed one differentially expressed O-glycosylated protein in 
a HepG2 cell line knockdown of SLC35b4  
 
 Size of differentially expressed protein “X” was determined to be approximately 
67.46 kDa 
 
 Two dimensional electrophoresis study of SLC35b4 knockdown resulted in: 
- The differential expression of 10 proteins, more than 2 fold, as compared to 
control siRNA 
- Three proteins were determined to be over-expressed as compared to control 
- Seven proteins were determined to be under-expressed as compare to control 
- The estimation of MW and pI of these 10 differentially expressed proteins 
- Three of the differentially expressed proteins (corresponding to Spots SSP 6203, 
6204 and 8102) have very close matches in O-glycosylated proteins of the insulin 
resistance pathway where O-glycosylation might play a role in glucose synthesis 
 
 Identification of differentially expressed protein is a must in order to assess 
SLC35b4 role in the IR pathway using its knockdown 
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